“10-Year Hits 5% as Fed Meeting Kicks Off | PreMarket Playbook + T3 Live | September 15, 2026”
GTBP carries risk from historical reverse splits and expected future capital raises/dilution needed for clinical trial funding.
Can we take a look at GT Biioarma today? It's been on a nice uptrend. Yeah, we can absolutely take a look at that. I did see that it basically traded up to its 200 day. So, um we'll see what uh GTBP does here today.
I did put it in another window. If I forget when we get to the stock section, remind me. We'll get to that.